1353P Prediction of the risk of recurrence in patients with non-small cell lung cancer using an integrated claims and electronic medical record database

Abstract

It has been estimated that more than 30% of patients with early stage non-small cell lung cancer (NSCLC) develop recurrence despite curative intent resection. Identification of these patients may permit targeting of patients most likely to benefit from adjuvant treatment.